{"parse":{"title":"Assay sensitivity","pageid":2221642,"revid":802071741,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Assay_sensitivity&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(September 2007)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b>Assay sensitivity</b> is a property of a <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a> defined as the ability of a trial to distinguish an effective <a href=\"/wiki/Therapy\" title=\"Therapy\">treatment</a> from a less effective or ineffective intervention. Without assay sensitivity, a trial is not <a href=\"/wiki/Internal_validity\" title=\"Internal validity\">internally valid</a> and is not capable of comparing the <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> of two interventions.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Importance\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Importance</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Differences_in_sensitivity\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Differences in sensitivity</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Importance\">Importance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Assay_sensitivity&amp;action=edit&amp;section=1\" title=\"Edit section: Importance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Lack of assay sensitivity has different implications for trials intended to show a difference greater than zero between interventions (superiority trials) and trials intended to show non-inferiority. Non-inferiority trials attempt to rule out some margin of inferiority between a test and control intervention i.e. rule out that the test intervention is no worse than the control intervention by a chosen amount.\n</p><p>If a trial intended to demonstrate efficacy by showing superiority of a test intervention to <a href=\"/wiki/Scientific_control\" title=\"Scientific control\">control</a> lacks assay sensitivity, it will fail to show that the test intervention is superior and will fail to lead to a conclusion of efficacy.\n</p><p>In contrast, if a trial intended to demonstrate efficacy by showing a test intervention is non-inferior to an active control lacks assay sensitivity, the trial may find an ineffective intervention to be non-inferior and could lead to an erroneous conclusion of efficacy.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> \n</p><p><br />\nWhen two interventions within a trial are shown to have different efficacy (i.e., when one intervention is superior), that finding itself directly demonstrates that the trial had assay sensitivity (assuming the finding is not related to random or systematic error). In contrast, a trial that demonstrates non-inferiority between two interventions, or an unsuccessful superiority trial, generally does not contain such direct evidence of assay sensitivity.\n</p>\n<h2><span class=\"mw-headline\" id=\"Differences_in_sensitivity\">Differences in sensitivity</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Assay_sensitivity&amp;action=edit&amp;section=2\" title=\"Edit section: Differences in sensitivity\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Assay sensitivity for a non-inferiority trial may depend upon the chosen margin of inferiority ruled out by the trial, and the design of the planned non-inferiority trial.  The chosen margin of inferiority in a non-inferiority trial cannot be larger than the largest effect size which the control intervention reliably and reproducibly demonstrates compared to <a href=\"/wiki/Placebo-controlled_studies\" class=\"mw-redirect\" title=\"Placebo-controlled studies\">placebo</a> or no treatment in past superiority trials.  For instance, if there is reliable and reproducible evidence from previous superiority trials of an effect size of 10% for a control intervention compared to placebo, an appropriately designed non-inferiorty trial designed to rule out that the test intervention may be as much as 5% less effective than the control would have assay sensitivity. On the other hand, with this same data, a noninferiority trial designed to rule out that the test intervention may be as much as 15% less effective than the control may not have assay sensitivity, since this trial would not ensure that the test intervention is any more effective than a placebo given that the effect ruled out is larger than the effect of the control compared to placebo.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> The choice of the margin is sometimes problematic in non-inferiority trials. Given investigators desire to choose larger margins to decrease the sample size needed to perform a trial, the chosen margin is sometimes larger than the effect size of the control compared to placebo.  In addition, a valid noninferiority trial is not possible in situations in which there is a lack of data demonstrating a reliable and reproducible effect of the control compared to placebo. \n</p><p>In addition to choosing a margin based upon credible past evidence, to have assay sensitivity, the planned non-inferiority trial must be designed in a way similar to the past trials which demonstrated the effectiveness of the control compared to placebo, the so-called \"constancy assumption\". In this way, non-inferiority trials have a feature in common with external (historically) controlled trials. This also means that non-inferiority trials are subject to some of the same biases as historically controlled trials; that is, the effect of a drug in a past trial may not be the same in a current trial given changes in medical practice, differences in disease definitions or changes in the natural history of a disease, differences in outcome timing and definitions, usage of concomitant medications, etc.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>The finding of  \"difference\" or \"no difference\" between two interventions is not a direct demonstration of the internal validity of the trial unless another internal control confirms that the study methods have the ability to show a difference, if one exists, over the range of interest (i.e. the trial contains a third group receiving placebo). Since most clinical trials do not contain an internal \"negative\" control (i.e. a placebo group) to internally validate the trial, the data to evaluate the validity of the trial comes from past trials external to the current trial.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Assay_sensitivity&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Sensitivity_(tests)\" class=\"mw-redirect\" title=\"Sensitivity (tests)\">Sensitivity (tests)</a></li>\n<li><a href=\"/wiki/Specificity_(tests)\" class=\"mw-redirect\" title=\"Specificity (tests)\">Specificity (tests)</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Assay_sensitivity&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Snapinn, SM (2000). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC59590\">\"Noninferiority trials\"</a>. <i>Current controlled trials in cardiovascular medicine</i>. <b>1</b> (1): 19\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/cvm-1-1-019\">10.1186/cvm-1-1-019</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC59590\">59590</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11714400\">11714400</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+controlled+trials+in+cardiovascular+medicine&amp;rft.atitle=Noninferiority+trials.&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=19-21&amp;rft.date=2000&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC59590&amp;rft_id=info%3Apmid%2F11714400&amp;rft_id=info%3Adoi%2F10.1186%2Fcvm-1-1-019&amp;rft.aulast=Snapinn&amp;rft.aufirst=SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC59590&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAssay+sensitivity\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Temple, Robert J (2002-02-19). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/ohrms/dockets/ac/02/slides/3837s1_02_Temple.ppt\">\"Active Control Non-Inferiority Studies: Theory, Assay Sensitivity, Choice of Margin\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-09-16</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Active+Control+Non-Inferiority+Studies%3A+Theory%2C+Assay+Sensitivity%2C+Choice+of+Margin&amp;rft.date=2002-02-19&amp;rft.au=Temple%2C+Robert+J&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F02%2Fslides%2F3837s1_02_Temple.ppt&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAssay+sensitivity\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">International Conference on Harmonization Guidance E-10 (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20050216053606/http://www.ich.org/MediaServer.jser?%40_ID=486&amp;%40_MODE=GLB\">\"Choice of Control Group and Related Issues in Clinical Trials\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org/MediaServer.jser?@_ID=486&amp;@_MODE=GLB\">the original</a> on 2005-02-16<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-10-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Choice+of+Control+Group+and+Related+Issues+in+Clinical+Trials&amp;rft.date=2000&amp;rft.au=International+Conference+on+Harmonization+Guidance+E-10&amp;rft_id=http%3A%2F%2Fwww.ich.org%2FMediaServer.jser%3F%40_ID%3D486%26%40_MODE%3DGLB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAssay+sensitivity\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Assay_sensitivity&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.clinicaltrials.gov/\">ClinicalTrials.gov</a> from US <a href=\"/wiki/National_Library_of_Medicine\" class=\"mw-redirect\" title=\"National Library of Medicine\">National Library of Medicine</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/\">FDA Website</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1232\nCached time: 20180908012309\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.112 seconds\nReal time usage: 0.143 seconds\nPreprocessor visited node count: 258/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 9953/2097152 bytes\nTemplate argument size: 95/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4374/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.053/10.000 seconds\nLua memory usage: 2.17 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  121.939      1 -total\n 55.39%   67.544      1 Template:Reflist\n 41.59%   50.713      1 Template:Refimprove\n 31.28%   38.142      1 Template:Cite_journal\n 26.08%   31.800      1 Template:Ambox\n 10.52%   12.827      2 Template:Cite_web\n  2.04%    2.482      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:2221642-0!canonical and timestamp 20180908012309 and revision id 802071741\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_September_2007"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","*":"Clinical_research"},{"sortkey":"","*":"Pharmaceutical_industry"},{"sortkey":"","*":"Clinical_trials"}],"links":[{"ns":14,"exists":"","*":"Category:Articles needing additional references from September 2007"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Internal validity"},{"ns":0,"exists":"","*":"National Library of Medicine"},{"ns":0,"exists":"","*":"Placebo-controlled studies"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Scientific control"},{"ns":0,"exists":"","*":"Sensitivity (tests)"},{"ns":0,"exists":"","*":"Specificity (tests)"},{"ns":0,"exists":"","*":"Therapy"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg","Question_book-new.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC59590","//doi.org/10.1186/cvm-1-1-019","//www.ncbi.nlm.nih.gov/pubmed/11714400","http://www.fda.gov/ohrms/dockets/ac/02/slides/3837s1_02_Temple.ppt","https://web.archive.org/web/20050216053606/http://www.ich.org/MediaServer.jser?@_ID=486&@_MODE=GLB","http://www.ich.org/MediaServer.jser?@_ID=486&@_MODE=GLB","http://www.clinicaltrials.gov/","http://www.fda.gov/"],"sections":[{"toclevel":1,"level":"2","line":"Importance","number":"1","index":"1","fromtitle":"Assay_sensitivity","byteoffset":386,"anchor":"Importance"},{"toclevel":1,"level":"2","line":"Differences in sensitivity","number":"2","index":"2","fromtitle":"Assay_sensitivity","byteoffset":2036,"anchor":"Differences_in_sensitivity"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"Assay_sensitivity","byteoffset":5778,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Assay_sensitivity","byteoffset":5844,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Assay_sensitivity","byteoffset":5874,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Assay sensitivity","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q4808618"}]}}